Periungual pyogenic granulomas after ravulizumab therapy in a child with acute myelomonocytic leukemia treated with hematopoietic stem cell transplant.
Pediatr Dermatol
; 41(5): 940-941, 2024.
Article
em En
| MEDLINE
| ID: mdl-38858093
ABSTRACT
Development of periungual pyogenic granulomas (pPGs) has been associated with several systemic treatments, including retinoids, taxanes, epidermal growth factor receptor inhibitors, and vascular endothelial growth factor inhibitors. We present the case of an 8-year-old girl with a personal history of acute myelomonocytic leukemia treated with a haploidentical hematopoietic stem cell transplant who developed pPGs 2 months after starting ravulizumab. Ravulizumab is a monoclonal antibody directed against C5 protein. No previous reports of pPGs development have been described with ravulizumab.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Leucemia Mielomonocítica Aguda
/
Granuloma Piogênico
/
Transplante de Células-Tronco Hematopoéticas
/
Anticorpos Monoclonais Humanizados
/
Doenças da Unha
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article